Related Experiment Video
Updated: Jun 3, 2026
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Drug target identification from protein dynamics using quantitative pathway analysis
David M Good1, Roman A Zubarev
1Chemistry I, Department of Molecular Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 171 77 Stockholm, Sweden.
Abstract:
Dynamic proteomics promises to greatly facilitate identification of target proteins for drug molecules. Cohen et al. [Science, 2008, 322 (5907), 1511-1516] illustrated this potential, with the responses of 812 fluorescently tagged proteins to camptothecin administration monitored over 48 h. Directly from this data, one can restrict the list of candidate targets to 52 proteins. However, this approach has numerous limitations: equipment, labor (tagging and analyzing ≥1 colony/protein), and data analysis (aggregating individual cell data into population-relevant data sets). Furthermore, analytical success requires both explicit knowledge of drug target time-course evolution and, most importantly, monitoring of the target, itself. To address these issues, we developed a quantitative pathway analysis (qPA) technique, which employs well-annotated signaling pathways and elucidates putative drug targets and other molecules of interest. qPA, using more general assumptions and only 3 out of 144 available time points, identified the single known camptothecin target, TOPI, among only a handful of putative targets. Importantly, identification was possible without containing TOPI within the input data. These results demonstrate the potential of qPA in drug target discovery and highlight the importance of systems biology approaches for analysis of proteomics data.
Insights
Quantitative pathway analysis (qPA) offers a powerful systems biology approach for drug target discovery. This method efficiently identifies potential drug targets from proteomics data, overcoming limitations of traditional dynamic proteomics techniques.
Area of Science:
- Proteomics
- Systems Biology
- Pharmacology
Background:
- Dynamic proteomics enables identification of drug target proteins by monitoring protein responses over time.
- Previous studies, like Cohen et al. (2008), demonstrated potential but faced limitations in equipment, labor, and data analysis.
- Accurate drug target identification requires knowledge of target time-course evolution and direct monitoring.
Purpose of the Study:
- To develop a quantitative pathway analysis (qPA) technique to overcome limitations in dynamic proteomics for drug target discovery.
- To elucidate putative drug targets and other molecules of interest using well-annotated signaling pathways.
- To demonstrate the efficacy of qPA in identifying known drug targets even without their explicit inclusion in the input data.
Main Methods:
- Developed a quantitative pathway analysis (qPA) technique.
- Employed well-annotated signaling pathways for analysis.
- Utilized general assumptions and a limited number of time points (3 out of 144) from proteomics data.
Main Results:
- qPA successfully identified the known camptothecin target, TOPI, among a small set of putative targets.
- Identification of TOPI was achieved without TOPI being explicitly included in the input data.
- The method demonstrated efficiency using fewer data points compared to traditional dynamic proteomics.
Conclusions:
- Quantitative pathway analysis (qPA) is a promising technique for drug target discovery.
- qPA effectively analyzes proteomics data by leveraging systems biology principles.
- This approach addresses key limitations of conventional dynamic proteomics, enhancing efficiency and accuracy.
More Related Videos
Related Concept Videos
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:04Protein-protein Interfaces